Upcoming events
May 13th–18th 2022 | San Francisco, CA
Come visit us at booth 1908 to learn more about Veracyte’s genomic diagnostic tests for interstitial lung disease and lung cancer.
Presented by: Dr. Lisa Lancaster
Presented by: Dr. David Feller-Kopman and Dr. Shaheen Islam
Updated 2022 ILD Diagnosis & Treatment Guidelines
Get the Latest Guidance and Updates Including the Role of Envisia Genomic Classifier
ATS 2022 | Industry Theater
Integrating the Percepta Genomic Sequencing Classifier for Lung Nodule Risk Stratification
ATS 2022 | Industry Theater
Integrating Novel Genomic Data to Improve ILD Diagnostic and Prognostic Confidence
ATS 2022 Poster Presentation | Percepta Nasal Swab
A Nasal Genomic Classifier for Assessing Risk of Malignancy in Lung Nodules Demonstrates Similar Performance in Patients that Meet Screening ...
Start a conversation
Contact us for more information or if you have any questions about Veracyte’s suite of genomic tests for lung disease.